Fulgent Genetics, Inc. (FLGT) stock
FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3046% below fair value
$24.66−0.19 (-0.76%)
Close on Nov 13, 2026Market cap $678.53MP/E –Yield –
Fulgent Genetics gross margin
Gross margin is gross profit as a percentage of revenue.
Fulgent Genetics's gross margin for the twelve months ending Sep 30, 2026 was 33.8%. For fiscal 2025 it was 40.6%, against 37.8% the year before. The highest annual figure on record is 78.7% in fiscal 2020.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 40.6% | +2.7 |
| FY2024 | Dec 31, 2024 | 37.8% | +1.7 |
| FY2023 | Dec 31, 2023 | 36.1% | −23.2 |
| FY2022 | Dec 31, 2022 | 59.3% | −19.0 |
| FY2021 | Dec 31, 2021 | 78.3% | −0.4 |
| FY2020 | Dec 31, 2020 | 78.7% | +22.1 |
| FY2019 | Dec 31, 2019 | 56.6% | +6.7 |
| FY2018 | Dec 31, 2018 | 49.9% | −4.4 |
| FY2017 | Dec 31, 2017 | 54.3% | −8.9 |
| FY2016 | Dec 31, 2016 | 63.2% | +16.2 |
| FY2015 | Dec 31, 2015 | 47.1% | +20.3 |
| FY2014 | Dec 31, 2014 | 26.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 35.3% | −6.9 |
| Q2 FY2026 | Jun 30, 2026 | 30.1% | −12.0 |
| Q1 FY2026 | Mar 31, 2026 | 30.2% | −8.4 |
| Q4 FY2025 | Dec 31, 2025 | 39.1% | −2.7 |
| Q3 FY2025 | Sep 30, 2025 | 42.2% | +4.9 |
| Q2 FY2025 | Jun 30, 2025 | 42.1% | +4.8 |
| Q1 FY2025 | Mar 31, 2025 | 38.6% | +4.3 |
| Q4 FY2024 | Dec 31, 2024 | 41.8% | +6.0 |
| Q3 FY2024 | Sep 30, 2024 | 37.3% | −9.7 |
| Q2 FY2024 | Jun 30, 2024 | 37.3% | +7.0 |
| Q1 FY2024 | Mar 31, 2024 | 34.3% | +5.8 |
| Q4 FY2023 | Dec 31, 2023 | 35.8% | +16.6 |
| Q3 FY2023 | Sep 30, 2023 | 47.0% | +3.4 |
| Q2 FY2023 | Jun 30, 2023 | 30.3% | −21.8 |
| Q1 FY2023 | Mar 31, 2023 | 28.4% | −47.3 |
| Q4 FY2022 | Dec 31, 2022 | 19.2% | −56.1 |
| Q3 FY2022 | Sep 30, 2022 | 43.6% | −37.3 |
| Q2 FY2022 | Jun 30, 2022 | 52.1% | −24.6 |
| Q1 FY2022 | Mar 31, 2022 | 75.7% | −3.7 |
| Q4 FY2021 | Dec 31, 2021 | 75.3% | −7.1 |
| Q3 FY2021 | Sep 30, 2021 | 80.9% | +6.7 |
| Q2 FY2021 | Jun 30, 2021 | 76.7% | +21.4 |
| Q1 FY2021 | Mar 31, 2021 | 79.4% | +31.7 |
| Q4 FY2020 | Dec 31, 2020 | 82.4% | +25.8 |
| Q3 FY2020 | Sep 30, 2020 | 74.2% | +11.7 |
| Q2 FY2020 | Jun 30, 2020 | 55.3% | −1.7 |
| Q1 FY2020 | Mar 31, 2020 | 47.7% | +2.9 |
| Q4 FY2019 | Dec 31, 2019 | 56.7% | +5.5 |
| Q3 FY2019 | Sep 30, 2019 | 62.5% | +8.9 |
| Q2 FY2019 | Jun 30, 2019 | 57.0% | +4.1 |
| Q1 FY2019 | Mar 31, 2019 | 44.7% | +4.3 |
| Q4 FY2018 | Dec 31, 2018 | 51.2% | +10.6 |
| Q3 FY2018 | Sep 30, 2018 | 53.6% | +3.9 |
| Q2 FY2018 | Jun 30, 2018 | 52.9% | −6.6 |
| Q1 FY2018 | Mar 31, 2018 | 40.4% | −24.5 |
| Q4 FY2017 | Dec 31, 2017 | 40.6% | −27.6 |
| Q3 FY2017 | Sep 30, 2017 | 49.6% | – |
| Q2 FY2017 | Jun 30, 2017 | 59.5% | – |
| Q1 FY2017 | Mar 31, 2017 | 65.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 68.2% | – |
See a number that looks wrong?